DENTSPLY SIRONA (NASDAQ:XRAY) Stock Gets Price Target Reduction from JPMorgan Chase & Co.

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price reduced by JPMorgan Chase & Co. from $12.00 to $10.00 in a report issued on Friday morning,Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

Several other brokerages have also issued reports on XRAY. BMO Capital Markets reduced their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a report on Thursday, September 17th. Leerink Partners decreased their target price on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating on the stock in a research report on Wednesday, October 14th. Barclays increased their target price on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research note on Monday, August 24th. Mizuho dropped their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Thursday, October 22nd. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Three equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $12.42.

DENTSPLY SIRONA Stock Performance

XRAY opened at $9.46 on Friday. The stock has a market capitalization of $1.89 billion, a PE ratio of -15.26, a P/E/G ratio of 1.27 and a beta of 0.87. DENTSPLY SIRONA has a one year low of $8.14 and a one year high of $14.76. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.04 and a current ratio of 1.63. The business’s 50 day moving average price is $9.60 and its 200 day moving average price is $11.28.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.02). DENTSPLY SIRONA had a positive return on equity of 20.21% and a negative net margin of 3.38%. The business had revenue of $836.00 million for the quarter, compared to analyst estimates of $861.68 million. During the same period last year, the business earned $0.37 EPS. DENTSPLY SIRONA’s revenue was down 7.5% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. As a group, equities research analysts expect that DENTSPLY SIRONA will post 1.33 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Altar Rock LLC acquired a new position in shares of DENTSPLY SIRONA during the third quarter worth about $131,000. AlphaCore Capital LLC raised its holdings in DENTSPLY SIRONA by 9.9% in the third quarter. AlphaCore Capital LLC now owns 14,386 shares of the medical instruments supplier’s stock valued at $127,000 after acquiring an additional 1,298 shares in the last quarter. Private Management Group Inc. raised its holdings in DENTSPLY SIRONA by 18.9% in the third quarter. Private Management Group Inc. now owns 2,936,998 shares of the medical instruments supplier’s stock valued at $26,022,000 after acquiring an additional 466,272 shares in the last quarter. Fulcrum Asset Management LLP purchased a new position in DENTSPLY SIRONA in the third quarter worth approximately $249,000. Finally, Brighton Jones LLC lifted its stake in DENTSPLY SIRONA by 7.6% in the third quarter. Brighton Jones LLC now owns 37,673 shares of the medical instruments supplier’s stock worth $334,000 after acquiring an additional 2,668 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.